期刊
FUTURE ONCOLOGY
卷 15, 期 26, 页码 3053-3069出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2019-0116
关键词
adoptive transfer; cancer stem cells; CAR-NK; clinical trials; immune escape; immune surveillance; NK cells; receptor signaling modulation; solid tumors
类别
Natural killer (NK) cells lead immune surveillance against cancer and early elimination of small tumors. Owing to their ability to engage tumor targets without the need of specific antigen, the therapeutic potential of NK cells has been extensively explored in hematological malignancies. In solid tumors, however, their role in the clinical arena remains poorly exploited despite a broad accumulation of preclinical data. In this article, we review our current knowledge of NK cells' biology, and highlight the challenges facing NK cell antitumor strategies in solid tumors. We further summarize the abundant preclinical attempts at overcoming these challenges, present past and ongoing clinical trial data and finally discuss the potential impact of novel insights on the development of NK cell-based therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据